X4 Pharmaceuticals (XFOR) to Offer Common Stock and Warrants

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR) announced today that it has commenced an underwritten public offering of shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof) and Class B warrants to purchase its common stock. All of the securities in the offering will be sold by X4. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

Cowen and Stifel are acting as joint book-running managers for the offering. Canaccord Genuity and Oppenheimer & Co. are acting as lead managers, and H.C. Wainwright & Co. and Roth Capital Partners are acting as managers for the offering.

You May Also Be Interested In

• Zentalis closes $92.6M public offering of common stock
• Stifel Reiterates Buy Rating on CrowdStrike (CRWD)
• Evolution Petroleum launches stock offering to fund Permian Basin deal